glp-1 tirzepatide vs semaglutide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management tirzepatide vs semaglutide mechanism difference

These drugs offer substantial potential health benefits, but the combination of intense demand, new uses, and high prices for these treatments is likely to place tremendous pressure on Medicare spending, Part D plan costs, and premiums for Part D coverage.

Last reviewed: June 12, 2026 Last updated: June 12, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

[8] [1] The Summary of Product Characteristics (SmPC) for all GLP-1 receptor agonists contains warnings about pancreatitis risk

Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity

has already achieved significant results in diabetes treatment and weight management